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Background: Osseous metastatic involvement of the spinal column affects many patients with a primary tumour
disease of all entities. The consequences are pain both at rest and under exertion, impairments in going about
day-to-day activities, diminished performance, the risk of pathological fractures, and neurological deficits. Palliative
percutaneous radiotherapy is one of the therapeutical options available in this connection. The aim of this
explorative study is to investigate the feasibility of muscle-training exercises and to evaluate the progression- and
fracture-free survival time and the improvement of bone density, as well as to assess other clinical parameters such
as pain, quality of life, and fatigue as secondary endpoints.
Methods/Design: This study is a prospective, randomized, monocentre, controlled explorative intervention study in
the parallel-group design to determine the multidimensional effects of a course of exercises at first under
physiotherapeutic instruction and subsequently performed by the patients independently for strengthening the
paravertebral muscles of patients with metastases of the vertebral column parallel to their percutaneous
radiotherapy. On the days of radiation treatment the patients in the control group shall be given physical
treatment in the form of respiratory therapy and the so-called “hot roll”. The patients will be randomized into one
of the two groups: differentiated muscle training or physiotherapy with thirty patients in each group.
Discussion: The aim of the study is to evaluate the feasibility of the training programme described here.
Progression-free and fracture-free survival, improved response to radiotherapy by means of bone density, and
clinical parameters such as pain, quality of life, and fatigue constitute secondary study objectives.
Trial Registration: ClinicalTrials.gov: NCT01409720
Background
Osseous metastatic involvement of the spinal column
affects many patients with a primary tumour disease of
all entities. In many cases this involvement is indicative of a
progressed stage of a primary malignant disease. 70 percent
of all patients who die of the sequelae of the tumour disease
exhibit bone metastases [1]. 80 percent of all osseous
metastases originate from mammary, prostatic, bronchial,
renal-cell, or thyroid carcinomas [2]. In men, the primary
tumour in 60 percent of all cases is a carcinoma of the
prostate [3], among women, it is in 70 percent of the cases
a mammary carcinoma. 30 percent of all metastases of the
skeletal system and ten percent of all primary bone
tumours are found in the spinal column. The former are
located in the lumbar (52%), thoracic (36%) and cervical
column (12%) [4]. The consequences are pain both at rest
and under exertion, impairments in going about day-to-day
activities, diminished performance, the risk of pathological
fractures, and neurological deficits. Pain is the essential
factor for the decrease in the quality of life of patients
with bone metastases [5]. Pathological fractures occur in
5% and compressions of the spinal cord in 10-15% of all
patients [6]. In its role as the central axial organ, the spinal
column stands in the focus of all mobility options of the
individual patient and, when compromised, constitutes a
mobility-restricting factor. The generation of power by the
paravertebral muscles and the patient’s mobility corre-
spondingly play a decisive role regarding his/her quality of
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any medium, provided the original work is properly cited.life. In their study involving patients with an advanced
tumour disorder, Cheville et al. [7] were able to demon-
strate that physiotherapy can be performed parallel to
radiotherapy with a beneficial effect. The primary intention
of this study is to review the feasibility of the project.
Strengthening the paravertebral muscular system is
reported to have a positive effect not only on the sensation
of pain, but also on the quality of life and fatigue. Isometric
training of the paravertebral muscles is anticipated to pro-
duce a raised perfusion of the segments of the vertebral col-
umn involved. This aspect may, in combination with
percutaneous radiotherapy, result in a better response to
therapy. The potentially raised risk of fracture in combina-
tion with an injury of the spinal cord involving neurological
deficits results in patients suffering a constant state of anxi-
ety of varying distinction. In most cases, this fear of such a
serious event in turn results in an unintended “vicious cir-
cle” comprising immobility, pain, and ever-decreasing phy-
sical performance. Pain, anxiety, and impaired physical
mobility are in virtually all cases associated with a reduced
quality of life and frequently result in negative conse-
quences for the patients’ participation in society. This con-
trolled combination therapy may relieve the negative effects
of the tumour disease for the patients. The literature has so
far not described any dedicated ergotherapeutical measures
employing isometric muscle training in connection with
bone metastases. The extent to which specific, regular, and
differentiated training of the paravertebral muscle system
can be performed may be jeopardized by the reduced gen-
eral condition of the patients, their pain situation, and their
fear of suffering fractures, which is why the feasibility of the
study poses the greatest challenge. In terms of the localiza-
tion and pain symptoms, these are similar to the complaints
experienced in osteoporosis and vertebral-disk syndromes.
Among these patients there are numerous indications of
the positive effect of targeted physical exercise on pain and
mobility [8-11]. The findings of this direction of research
shall also be considered in this study. Patients undergoing
treatment in the form of percutaneous radiotherapy who
from the orthopedic and radiological aspects are classified
as not being at risk of suffering fractures will receive a sec-
ond component of therapy involving isometric training of
the paravertebral muscle system.
Methods/design
This study is a prospective, randomized, monocentre, con-
trolled explorative intervention study in the parallel-group
design to determine the multidimensional effects of a
course of exercises at first under physiotherapeutic
instruction and subsequently performed by the patients
independently for strengthening the paravertebral muscles
of patients with metastases of the vertebral column parallel
to their percutaneous radiotherapy (Figure 1). Since the
osseous metastases of the individual patients may be
located at different levels of the vertebral column, three
different types of exercises have been selected to ensure an
even isometric training of all vertebral-column muscles.
On the days of radiation treatment the patients in the con-
trol group shall be given physical treatment in the form of
respiratory therapy and the so-called “hot roll”. The plan
foresees the recruitment, over a period of twelve months,
of a total of 60 patients with metastases of the vertebral
column who are scheduled to undergo radiotherapy. Prior
to their enrolment into the study, the patients will undergo
a staging of the vertebral column in connection with their
radiation-planning CT to measure the bone density. After
the baseline results have been recorded, the patients will
be randomized into one of the two groups: differentiated
muscle training (n = 30) or physiotherapy (n = 30). The
interventions will start at the same time as radiotherapy,
taking place on each day of irradiation (Mondays thru Fri-
days) for a period of two weeks. Each sport intervention
will last approx. 30 minutes, the physiotherapy measure
approx. 15 minutes over a two-week period. After the end
of the radiotherapy/after two weeks, the patients partici-
pating in the training group will continue to do the exer-
cises started under the instruction of the therapist on their
own at their homes, recording the exercises and the pain
load in a daily protocol report. The participants in the
control group will not do any exercises or measures at
home. The target parameters will be measured and
recorded at the end of the irradiation period (t1)a n d
twelve weeks (t2) and six months following the end of the
irradiation period (t3). Follow-up measurements are sched-
uled to take place twelve, 18, and 24 months after the end
of irradiation.
Recruitment and randomization
The patients will be given information on the study by
the medical personnel of the Radiotherapy Department
in connection with the planning of the radiotherapy regi-
men (approx. 1-2 weeks prior to the start of radiother-
apy). If they are interested in participating in the study,
the potential study candidates will be given the Patient
Information sheet including the Declaration of Informed
Consent, with the request that they reread the informa-
tion carefully and if they consent to the conditions return
the signed declaration when they attend the next
appointment. The patients will be given the opportunity
to ask the study staff further questions. Among the pre-
conditions for participation in the study is the condition
that no acute instability of the metastasized vertebral
body is detected in CT recorded in the course of plan-
ning the radiotherapy regimen.
A block randomization procedure shall be used to
ensure the even distribution of the patients into the two
intervention groups. The patients shall then be assigned
1:1 to one of the two treatment arms by the study director
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line measurements. The randomization procedure shall be
carried out by a central office. The study personnel
r e s p o n s i b l ef o rt h er e c r u i t m e n ta n db a s e l i n em e a s u r e -
ments shall have no access to the randomization list, and
the study director no influence on the recruitment of the
patients. The recruitment phase shall be concluded with
the attainment of the planned number of patients (60
patients in total). It shall last twelve months, and is sched-
uled to start in September 2011. Regular study participa-
tion shall end two years after enrolment into the study or,
where applicable, with the respective patient’sd e a t h .
Inclusion criteria
￿ Patients with a histologically secured tumour diag-
nosis, with secondarily diagnosed solitary/multiple
metastatic processes in the thoracic or lumbar spine
or in the os sacrum
￿ Indication for radiotherapy of the osseous meta-
static processes
￿ Age: between 18 and 80 years
￿ Karnofsky index [12,13] ≥ 70
￿ Signed Declaration of Informed Consent
￿ Bisphosphonate therapy
￿ No risk of fracture indicated by prior assessment per-
formed at t0 (the assessment of the instability shall be
made independently by a radiologist and a specialist
for A&E surgery/orthopedic specialist; two positive
votes are required)
Exclusion criteria
￿ Present vertebral-body instability
￿ Significant neurological or psychiatric disorders,
including dementia and epileptic seizures
￿ Other severe disorders that in the judgement of
the study director may prevent the patient’s partici-
pation in the study
￿ Lacking or diminished legal capacity
￿ Any medical of psychological condition that the
study director considers a preventive factor for the
patient’s ability to complete the study or to adequately
understand the scope of the study and to give his/her
consent
Intervention group
Sport concept: differentiated isometric exercise of the
autochthonous muscles
1. Exercises in the “all-fours” position:
Starting position: Arms and upper legs perpendicular to
the floor, hands and knees positioned vertically under the
shoulders and hips, respectively. The spine is as far as pos-
sible in the zero position over all segments. The elbows
are slightly flexed. From the starting position, the right
arm is anteverted in the shoulder from the sagittal level in
the ventrocranial direction, at the very most until it is hor-
izontal. The arm is then dropped again until it reaches the
starting position, but it does not touch the ground again
until the series of exercises is ended. The patient should
keep his/her spine completely stable while the arm is
being moved. The exercise is then repeated with the left
arm. Duration: two series per arm, repeating each series of
exercises ten times.
2. Exercises in the “gluteus arch” position:
Starting position: Lying on the back, the feet on the floor
drawn up to the trunk, the knees well bent, the arms lying
relaxed next to the body, the spine in the zero position as
far as physiologically possible. The patient then pushes
his/her posterior and back up from the floor. This move-
ment should be made until an extension/flexion zero posi-
tion in the hip is achieved. This caudal movement should
take place exclusively in the hip, with the spine remaining
in its physiological zero position in the lumbar and thor-
aco-lumbar and in the lower thoracic sections, with flexion
occurring only at the point of contact in the upper thor-
acic segments. After reaching the highest point of the
movement, the patient then lowers the trunk again until it
Week
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Figure 1 Flowchart of the study.
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movement without allowing the trunk to touch the floor.
Duration: two series, repeating the exercise ten times in
each series. Intervals between series: 60 to 90 seconds.
3. Exercises in the supine position:
Starting position: Lying on the back, the feet on the floor
drawn up to the trunk, the arms lying relaxed next to the
body, the spine in the zero position as far as physiologically
possible. The patient tips his/her pelvis at the sagittal level
in the dorsal direction, resulting in a delordosing of the
lumbar spine. This effect is produced by a dorsal displace-
ment of the two spinae iliacae posteriores superiores and a
caudal displacement of the os sacrum. The patient should
maintain this position of the pelvis and the lumbar spine,
and then lift his/her leg, drawing the knee in the direction
of the abdomen, with the other leg following suit. The legs
are then very slowly moved in the caudal direction and
subsequently drawn back towards the abdomen. Duration:
two series, repeating the movement four to eight times in
each series. Intervals between series: 60-90 seconds [14,15].
Control group
Physical measure: hot towel rolls with essential oils
The physical treatment of the patients in the control
group shall take the form of the ventro-thoracic applica-
tion of a so-called “hot roll”, a physiotherapeutic measure.
For this procedure, a suited towel is rolled up and hot
water poured on it so that all layers are thoroughly moist.
Essential oils can also be used, which then unfold their
effect as a result of the evaporation of the hot water. The
patient either sits or lies on his/her back, and the rolled
towel is carefully pressed onto his/her thorax, resulting in
a considerable warming effect in this area. The therapist
gradually unfolds the roll one layer at a time, dabbing the
patient’s skin with each warm layer of the towel in the
process. The patient is asked to comment on his/her com-
fort at regular intervals to ensure that the skin is not over-
heated; the patient should be as relaxed as possible at all
times, inhaling deeply to benefit from the respiratory-ther-
apeutic effect of the essential oils. Duration: approx. 15
minutes.
Questionnaire diagnostics
The secondary endpoints such as fatigue, quality of life,
and anxiety shall be recorded using validated question-
naires (EORTC QLQ C30 FA13 [16], EORTC QLQ C30
BM22 [17] and the questionnaire to record stress in can-
cer patients (FBK) acc. to Herschbach [18] (t0, 2, 3).
Furthermore, all patients will also be asked to record their
pain history using a pain diary (documentation of medica-
tion daily during treatment, once weekly after the end of
treatment, VAS pain scale).
Laboratory diagnostics
The blood samples taken at the recording intervals t0
(baseline examination first day of radiotherapy) and t2
(12 weeks after completion of radiotherapy) (30 ml from
a cubital vein) shall be processed within a time of max.
two hours (ELISA and functional analysis) or deep-fro-
zen at a temperature of -70°C for analysis at a later
time. The samples shall be analyzed at the Dr. Limbach
Laboratory in Heidelberg. The blood and urine samples
shall be taken at the t0 and t2 sampling times. The fol-
lowing parameters shall be analyzed: NTX (N-telopep-
tides from collagen I), CTX (carboxy-terminal collagen
crosslinks), PINP (procollagen (I) N-terminal propep-
tide), DPD-crosslinks (deoxypyridinoline crosslinks), and
Bone aP (bone-specific alkaline phosphatase).
Assessment of the therapeutic success
The aim of the study is to evaluate the feasibility of the
training programme described here. Progression-free and
fracture-free survival, improved response to radiotherapy
by means of bone density, and clinical parameters such
as pain, quality of life, and fatigue constitute secondary
study objectives. In addition, the changes between base-
line and Week 12 and Week 24 (end of intervention)
regarding pain symptoms between the intervention arm
(muscle exercises) and the control arm (physiotherapy)
shall be compared. The feasibility shall be expressed in
percent in tabular form and shall cover the complete per-
formance of the training programme up to the t2 interval.
As described above, the patients enrolled into the study
shall be subjected to a CT screening of the vertebral col-
umn with bone densimetry as per the standards of the
follow-up investigation (t2). Furthermore the psycho-
oncological parameters on t1, 2, 3 and the laboratory para-
meters on t0 and t2 shall be documented and evaluated.
Following the radiotherapy period the patients shall inde-
pendently keep a pain diary and a record of their training
exercises. No further radiological examinations shall be
conducted in the course of this study.
Clinical examinations
The baseline examination shall be carried out on the first
day of radiotherapy prior to the start of therapy and is
scheduled to comprise the comprehensive recording of the
sociodemographic data, the recording of the current pain
situation, the fear of suffering fractures, the quality of life,
the current degree of ability to go about day-to-day activ-
ities, and fatigue, and shall also involve the taking of blood
and urine samples. The follow-up examinations shall take
place after the end of radiotherapy (day of the last fraction)
and twelve weeks and six months after radiotherapy, mea-
suring those parameters recorded at the baseline examina-
tion. The further follow-up examinations shall correspond
to those carried out as standard after-care investigations.
Therapy drop-out criteria
￿ At the patient’s wish
￿ Medical condition requiring the discontinuation of
therapy in the opinion of the study director or
patient
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Study discontinuation
￿ Medical or ethical aspects that make it impossible
to continue the study
￿ Difficulties in recruiting participants that involve
an unreasonable prolongation of the study duration
￿ Adverse reactions that have not yet been reported
in their form, severity, duration, and impact
￿ Unexpectedly high incidence of already known
adverse reactions
￿ By official decision
Statistical analysis
The total number of patients undergoing radiotherapy in
the radiation oncology department of the Heidelberg Uni-
versity Clinic for metastatic processes in the vertebral col-
umn in the recruitment period is approx. 120, about 90 of
whom shall fulfill the inclusion criteria. The relatively
weakly distinct compliance of this group of patients not-
withstanding, it should be possible to achieve the planned
recruitment target within a period of six months. On
account of the explorative character of this study it is not
possible to estimate the total number of cases; with a
scheduled number of 30 patients per group, it will, how-
ever, be possible to detect a standardized mean-value
effect of 0.8 with a power of 80% and an a significance
level of 5%.
Ethical issues, information, and safety
The study protocol, Patient Information sheet, and
Declaration of Informed Consent shall be submitted to the
Heidelberg University Ethics Committee responsible for
the study directors for review. The study shall commence
only after receipt of the approval of the Ethics Committee.
The positive vote was given on the 1
st August 2011.
The study directors shall immediately notify the Ethics
Committee of all changes made in the study protocol that
may have an impact on the safety of the patients. Further-
more, the Ethics Committee shall also be notified of all
severe adverse events reported to the study directors and
of the regular or premature termination of the study. The
procedures described in the submitted study protocol
regarding the performance, evaluation, and documentation
of this study have been selected in such a way that the
principles of the Good Clinical Practice (GCP) guidelines
are observed. The regulations regarding medical confiden-
tiality and data protection are fulfilled.
Discussion
Bone-affecting metastatic processes in vertebral bodies
constitute a frequent secondary disorder in connection
with a variety of primary tumours. Palliative percutaneous
radiotherapy is one of the therapeutical options available
in this connection. On the one hand, symptoms such as
painful impairments of mobility, pain at rest, a fear of
pathological fractures, and fatigue result in a pronounced
diminution in the patients’ quality of life, while on the
other hand the therapy of such disorders involves pro-
tracted, cost- and time-intensive therapeutical measures.
Furthermore, in some cases there is an acute risk of frac-
ture with the danger of the emergence of symptoms of
paraplegia. Our point of departure is the assumption that
additional differentiated sport therapy aimed at strength-
ening the paravertebral muscle system can enhance the
impact of radiotherapy by exerting a positive effect on
clinical factors and bone density. The aim of this explora-
tive study is to investigate the feasibility of muscle-training
exercises and to evaluate the progression- and fracture-
free survival time and the improvement of bone density, as
well as to assess other clinical parameters such as pain,
quality of life, and fatigue as secondary endpoints. A
further objective of the study is to make a contribution to
the integration of a regimen of physical training exercises
with its multidimensional effects into future therapeutical
concepts for patients with osseous metastases of the ver-
tebral bodies.
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